JohnATaylorIiiMDMS

PubMed

• 2 citations
  Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex.
  Scott Weir, Prasad Dandawate, David Standing, Sangita Bhattacharyya, Prabhu Ramamoorthy, Parthasarathy Rangarajan, Robyn Wood, Amanda E. Brinker, Benjamin L. Woolbrigh...> ;Cell Death & Disease. 2021 May 31
• 20 citations
  Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours.
  Hugh Mostafid, Ashish M. Kamat, Siamak Daneshmand, Joan Palou, John A. Taylor, James M. McKiernan, James W.F. Catto, Marko Babjuk, Mark S. Soloway> ;European Urology Oncology. 2021 Feb 1
• 15 citations
  The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition.
  Sanket J. Mishra, Weiya Liu, Kristin Beebe, Monimoy Banerjee, Caitlin N. Kent, Vitumbiko Munthali, John Koren, John A. Taylor, Leonard M. Neckers, Jeffrey M. Holzbeier...> ;Journal of Medicinal Chemistry. 2021 Jan 11
• 1 citations
  Near-Miss Diagnoses of Solitary Bladder Tumors Highlight the Importance of Immunohistochemical Staining.
  Van Schloegel Schloegel, Syed M. Alam, Katie Dennis, Jeffrey M. Holzbeierlein, John A. Taylor> ;Case reports in urology. 2020 Dec 16
• 10 citations
  Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review.
  Connor Chestnut, Dharmalingam Subramaniam, Prasad Dandawate, Subhash Padhye, John A. Taylor, Scott Weir, Shrikant Anant> ;Nutrition and Cancer. 2020 Dec 11
• 72 citations
  What Is the Significance of Variant Histology in Urothelial Carcinoma
  Niyati Lobo, Shahrokh F. Shariat, Charles C. Guo, Mario I. Fernández, Wassim Kassouf, Ananya Choudhury, Jianjun Gao, Stephen B. Williams, Matthew D. Galsky, John A. Ta...> ;European urology focus. 2020 Jul 15
• 67 citations
  Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.
  Joshua J. Meeks, Hikmat Al-Ahmadie, Bishoy Faltas, John A. Taylor, Thomas W. Flaig, David J. DeGraff, Emil Christensen, Benjamin L. Woolbright, David J. McConkey, Lars...> ;Nature Reviews Urology. 2020 Mar 31
• 3 citations
  Salvage Therapy for Non–muscle-invasive Bladder Cancer: Novel Intravesical Agents
  Dunia Khaled, John A. Taylor, Jeffrey M. Holzbeierlein> ;Urologic Clinics of North America. 2020 Feb 1
• 8 citations
  Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials
  Benjamin L. Woolbright, Carol C. Pilbeam, John A. Taylor> ;Prostaglandins & Other Lipid Mediators. 2020 Jan 10
• 56 citations
  Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis.
  Benjamin L. Woolbright, Ganeshkumar Rajendran, Robert A. Harris, John A. Taylor> ;Molecular Cancer Therapeutics. 2019 Oct 1
• 9 citations
  Tumor M2-PK: A novel urine marker of bladder cancer.
  Weiya Liu, Benjamin L. Woolbright, Karim Pirani, Ryan Didde, Erika Abbott, Gaurav Kaushik, Paige Martin, Jill Hamilton-Reeves, John A. Taylor, Jeffrey M. Holzbeierlein...> ;PLOS ONE. 2019 Jun 27
• 12 citations
  Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs.
  Scott Weir, Robyn Wood, Karl Schorno, Amanda E. Brinker, Prabhu Ramamoorthy, Kathy Heppert, Lian G. Rajewski, Mehmet Tanol, Tammy Ham, Michael J. McKenna, William McCu...> ;Journal of Pharmacology and Experimental Therapeutics. 2019 Aug 1
• 3 citations
  Molecular subtyping of bladder cancer: current trends and future directions in 2019.
  Woodson Smelser, Benjamin L. Woolbright, John A. Taylor> ;Current Opinion in Urology. 2019 May 1
• 34 citations
  MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential.
  Justin Penticuff, Benjamin L. Woolbright, Thais M. Sielecki, Scott Weir, John A. Taylor> ;Nature Reviews Urology. 2019 Mar 26
• 3 citations
  A novel and accurate microfluidic assay of CD62L in bladder cancer serum samples.
  Gayatri S Phadke, Jennifer E. Satterwhite-Warden, Dharamainder Choudhary, John A. Taylor, James F. Rusling> ;Analyst. 2018 Nov 5
• 53 citations
  The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance
  Benjamin L. Woolbright, Dharamainder Choudhary, Andrew Mikhalyuk, Cassandra J Trammel, Sambantham Shanmugam, Erika Abbott, Carol C. Pilbeam, John A. Taylor> ;Molecular Cancer Therapeutics. 2018 Jun 15
• 24 citations
  Metabolic changes in bladder cancer.
  Benjamin L. Woolbright, Matthew Ayres, John A. Taylor> ;Urologic Oncology-seminars and Original Investigations. 2018 Jul 1
• 6 citations
  Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.
  Henry M. Smilowitz, Lauren J Tarmu, Mary M. Sanders, John A. Taylor, Dharamainder Choudhary, Crystal Xue, Nathaniel A. Dyment, Dan Sasso, Xiaomeng Deng, James F. Hainfeld> ;International Journal of Nanomedicine. 2017 Oct 27
• 8 citations
  SATB1 and bladder cancer: Is there a functional link?
  Dharamainder Choudhary, Jessica M. Clement, Shilpa Choudhary, Olga Voznesensky, Carol C. Pilbeam, Benjamin L. Woolbright, John A. Taylor> ;Urologic Oncology-seminars and Original Investigations. 2017 Oct 1
• 12 citations
  Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017...
  Ashish M. Kamat, Joaquim Bellmunt, Matthew D. Galsky, Badrinath R. Konety, Donald L. Lamm, David Langham, Cheryl T. Lee, Matthew I. Milowsky, Michael A. O’Donnell, Pet...> ;Journal for ImmunoTherapy of Cancer. 2017 Sep 28
• 3 citations
  Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.
  Thomas W. Flaig, Ashish M. Kamat, Donna E. Hansel, Molly A. Ingersoll, H. Barton Grossman, Cathy Mendelsohn, David J. DeGraff, Joseph C. Liao, John A. Taylor> ;Bladder cancer (Amsterdam, Netherlands). 2017 Jul 27
• 8 citations
  AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.
  Stavros Kopsiaftis, Poornima Hegde, John A. Taylor, Kevin P. Claffey> ;Translational Oncology. 2016 Dec 1
• 3 citations
  Innovation in Bladder Cancer Immunotherapy.
  H. Barton Grossman, Donald L. Lamm, Ashish M. Kamat, Stephen Michael Keefe, John A. Taylor, Molly A. Ingersoll> ;Journal of Immunotherapy. 2016 Oct 1
• 2 citations
  Hematospermia and Cloacogenic Transitional Cell Carcinoma: A Twist on Significance and Meaning.
  Alex M. Hennessey, Jessica M. Clement, Faripour Forouhar, John A. Taylor> ;Case reports in urology. 2016 Feb 8
• 13 citations
  AMPKα2 Regulates Bladder Cancer Growth through SKP2-Mediated Degradation of p27.
  Stavros Kopsiaftis, Katie L. Sullivan, Isha Garg, John A. Taylor, Kevin P. Claffey> ;Molecular Cancer Research. 2016 Jan 1
• Join now to see all

Journal Articles

• Innovation in bladder cancer immunotherapy  
  Grossman HB, Lamm DL, Kamat AM, Keefe S, Taylor JA, Ingersoll MA, J Immunother, 1/1/2016
• Urethral duct invasion in female urethral melanoma  
  Urban J, Bayart CB, Taylor JA, Hegde U, Forouhar F, Dadras SS, Human Pathology: Case Reports, 1/1/2016
• Collaborating to Move Research Forward: Proceedings from the 10th Annual Bladder Cancer Think Tank  
  Kamat AM, Agarwal P, Bivalacqua T, Chisolm S, Daneshmand S, Doroshow JH, Efstathiou JA, Galsky M, Iyer G, Kassouf W, Shah J, Taylor JA, Williams SB, Quale DZ, Rosenber..., Bladder Cancer, 1/1/2016
• What is the Urologist to do in a BCG Shortage?  
  Kamat AM, Lamm DL, O’Donnell M, Konety B, Williams S, Taylor JA, AUA News, 1/1/2014
• Bladder Cancer versus Hemorrhagic Cystitis: A Case of Mistaken Identity in a 34-year-old Male Undergoing Therapy for Wegener’s Granulomatosis  
  Amatruda J, Dieckhaus K, Hegde P, Taylor JA, Case Rep Nephrol Urol, 1/1/2014
• Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction  
  Taylor JA, Zhu Q, Irwin B, Maghaydah Y, Tsimikas J, Pilbeam C, Leng L, Bucala R, Kuchel GA, Am J Physiol Renal Physiol, 1/1/2006
• The relationship of ultra-sensitive PSA levels to prostate cancer recurrence after radical prostatectomy  
  Taylor JA, Koff SG, Dauser D, McLeod DG, Br J Urol, 1/1/2006
• Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage  
  Brassell SA, Krueger WR, Choi JH, Taylor JA, World J Urol, 1/1/2004
• Lower urinary tract symptoms in the older male  
  Hsieh K, Taylor JA, Albertsen PC, Conn Med, 1/1/2003
• Atypical small acinar proliferation: A clinically significant diagnostic category  
  Kambham N, Taylor JA, Troxel A, Rubin MA, J Urol Pathol, 1/1/1999
• Spontaneous renal artery dissection in a normal tensive young male  
  Taylor JA, Martin EC, Sawczuk I, Digital Urology Journal, 1/1/1996
• Pulmonary lymphangiomyomatosis in tuberous sclerosis: Association with chronic renal failure  
  Brisman JL, Kirsch AJ, Taylor JA, Birch BD, Hibshoosh HH, Kaplan SA, P&S Medical Review, 1/1/1994
• Join now to see all

Books/Book Chapters

• Geriatric Nursing Review Syllabus: A Core Curriculum in Advanced Practice Geriatric Nursing 
  Chapter: Question Contributor 
  Taylor JAEditors: Flaherty E, Resnick B.American Geriatrics Society, New YorkEdition 4th,2014
• Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine 
  Chapter: Question Contributor 
  Taylor JAEditors: Durso SC, Sullivan GM.American Geriatrics Society, New YorkEdition 8th,2013
• Principles and practice of Geriatric Surgery 
  Chapter: Benign and Malignant Diseases of the Prostate 
  Taylor JA, Albertsen PCEditors: Rosenthal, Zenilman and Katlic.Edition 2nd,2011
• The 5-Minute Urology Consult 
  Chapter: Alternative therapies for benign prostatic hyperplasia 
  Taylor JA, Lowe FCEditors: Gomella LG.Lippincott Williams & Wilkins, Philadelphia, PA2000
• Hosp Phys Urology Board Review Manual 
  Chapter: Minimally invasive therapies for benign prostatic hyperplasia 
  Taylor JAEditors: Moss E and Goluboff ET.1999
• Join now to see all

Abstracts/Posters

• Potential role of G1P3 in development of chemoresistance in high grade bladder cancer
  Alam SM, Choudhary D, Dancik G, Pilbeam CC, Taylor JA, J Urol, 1/1/2016
• Osteopontin – a potential marker for chemotherapy resistance in bladder cancer
  Gibson N, Choudhary D, Pilbeam CC, Taylor JA, J Urol, 1/1/2016
• Potential role of G1P3 in development of chemoresistance in high grade bladder cancer
  Taylor JA, American Urological Association Annual Meeting, Bladder Cancer Basic Science Session, San Diego, CA, 1/1/2016
• Osteopontin – a potential marker for chemotherapy resistance in bladder cancer
  Taylor JA, American Urological Association Annual Meeting, Bladder Cancer Basic Science Session, San Diego, CA, 1/1/2016
• Increased expression of PDK4 in bladder cancer cells
  Choudhary D, Mikhalyuk A, Pilbeam C, Taylor JA, Proceedings of the 106th Annual Meeting of the American Association for Cancer Research, Philidelphia, PA, 1/5/2015
• PDK4 – A possible therapeutic target for high grade bladder cancer
  Mikhalyuk A, Choudhary D, Pilbeam C, Taylor JA, J Urol, 1/1/2015
• PDK4 – A possible therapeutic target for high grade bladder cancer
  Taylor JA, American Urological Association Annual Meeting, Bladder Cancer Basic Science Session, New Orleans, LA, 1/1/2015
• Increased expression of PDK4 in bladder cancer cells
  Taylor JA, American Association of Cancer Research Annual Meeting, Philidelphia, PA, 1/1/2015
• Increased expression of L-selectin (CD62L) in high grade bladder cancer: a potential biomarker for lymph node metastasis
  Choudhary D, Hegde P, Voznesensky O, Choudhary S, Claffey KP, Srivastava P, Pilbeam CC, Taylor JA, Proceedings of the 105th Annual Meeting of the American Association for Cancer Research, Philidelphia, PA, 1/5/2014
• L-selectin (CD62L) expression in high grade urothelial carcinoma as a potential marker of metastatic disease
  Choudhary D, Hegde P, Voznesensky O, Choudhary S, Claffey KP, Srivastava P, Pilbeam CC, Taylor JA, J Urol, 1/1/2014
• Increased expression of L-selectin (CD62L) in high grade bladder cancer: a potential biomarker for lymph node metastasis
  Taylor JA, American Association of Cancer Research Annual Meeting, San Diego, CA, 1/1/2014
• Improving Cancer Diagnostics by an Integrated Program of Biorepositories and Next Generation Sequencing
  Everson RB, Perpetua LA, Gooch MJ, Swede H, Singh P, Farooq U, Weir R, Lee E, Zhou B, Glynn J, Burian L, Hollis V, Taylor JA, Smilowitz H, Sanders MM, Clinical Genomics of Cancer, Boston, MA, 1/1/2013
• Macrophage Migratory Inhibitory Factor (MIF) increases cell proliferation and cytokine expression in HTB5 bladder cancer cells
  Choudhary S, Pruitt JR, Sielecki TM, Pilbeam C, Taylor JA, Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research, Chicago, IL, 1/1/2012
• Macrophage Migratory Inhibitory Factor (MIF) increases cell proliferation and cytokine expression in HTB5 bladder cancer cells
  Taylor JA, American Association of Cancer Research Annual Meeting, Chicago, IL, 1/1/2012
• SATB1 expression increases resistance of bladder cancer cells to cisplatin
  Choudhary S, Voznesensky OS, Pilbeam C, Taylor JA, Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research, Orlando, FL, 1/11/2011
• Decreased inflammation and tumor stage in COX-2 knockout mice in the BBN model of bladder cancer
  Choudhary S, Hegde P, Pilbeam C, Taylor JA, Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research, Orlando, FL, 1/11/2011
• SATB1 expression increases resistance of bladder cancer cells to Cisplatin
  Taylor JA, American Association of Cancer Research Annual Meeting, Orlando, FL, 1/1/2011
• Decreased inflammation and tumor stage in COX-2 knockout mice in the BBN model of bladder cancer
  Taylor JA, American Association of Cancer Research Annual Meeting, Orlando, FL, 1/1/2011
• mPGES-1 gene deletion results in a statistically significant reduction in bladder cancer stage and tumor burden in a mouse model of invasive disease
  Nakanishi M, Choudhary S, Hegde P, Pilbeam C, Rosenberg D, Taylor JA, JUrol, 1/1/2010
• The Use of Oral inhibitors of Macrophage Migration Inhibitory Factor in a mouse model of bladder cancer significantly reduce tumor burden
  Taylor JA, Choudhary S, Hegde P, Voznesensky OS, de la Cruz VF, Pruitt JR, Sielecki TM, Pilbeam C, JUrol, 1/1/2010
• Oral inhibitors of Macrophage Migration Inhibitory Factor significantly reduce tumor burden in a mouse model of bladder cancer
  Taylor JA, Choudhary S, Hegde P, Voznesensky OS, de la Cruz VF, Pruitt JR, Sielecki TM, Pilbeam C, Proceedings of the AACR Annual Meeting, 1/1/2010
• Gene deletion of mPGES-1 results in a significant reduction in tumor stage and burden in the BBN mouse model of bladder cancer
  Nakanishi M, Choudhary S, Hegde P, Pilbeam C, Rosenberg D, Taylor JA, Proceedings of the AACR Annual Meeting, 1/1/2010
• Oral inhibitors of Macrophage Migration Inhibitory Factor significantly reduce tumor burden in a mouse model of bladder cancer
  Taylor JA, Choudhary S, Hegde P, Voznesensky OS, de la Cruz VF, Pruitt JR, Sielecki TM, Pilbeam C, ASCO, GU Symposium, 1/1/2010
• mPGES-1 gene deletion results in a statistically significant reduction in bladder cancer stage and tumor burden in a mouse model of invasive disease
  Taylor JA, American Urological Association Annual Meeting, San Francisco, CA, 1/1/2010
• Oral inhibitors of Macrophage Migratory Inhibitory Factor (MIF) lead to reduced tumor burden in a murine model of invasive bladder cancer in a dose dependant manner
  Taylor JA, American Association of Cancer Research Annual Meeting, Washington, DC, 1/1/2010
• Join now to see all

Lectures

• Management of high grade non-muslce invasive bladder cancer 
  San Diego, CA - 1/1/2016
• Concept to Reality the Albert Institute 
  Athens, Greece - 1/1/2015
• Immunotherapy and Bladder Cancer, What’s On the Horizon 
  Minneapolis, MN - 1/1/2015
• Translational Science in Bladder Cancer: From Bench to Bedside 
  Charlotte, NC - 1/1/2015
• Preclinical Modeling of Bladder Cancer; Potential Role of MIF Inhibition 
  University of Kansas, Cancer Center - 1/1/2015
• Bladder Cancer, Nodal Metastasis and CD62L A Potential Marker? 
  Montefiore Medical Center - 1/1/2015
• Markers of metastatic bladder cancer 
  Vancouver, BC - 1/1/2014
• L-selectin (CD62L) expression in high grade urothelial carcinoma as a potential marker of metastatic disease 
  Orlando, FL - 1/1/2014
• Comparison/Summary of Current Guidelines for Use of BCG 
  Hartford, CT - 1/1/2014
• Advances in urothelial cancer research 
  San Francisco, CA - 1/1/2014
• Current Guidelines for BCG Use in NMIBC; Standards and Recommendations 
  Rockville, MD - 1/1/2014
• Bladder Cancer and Advances in Care? The Possibilities are Endless 
  University of Connecticut - 1/1/2014
• Standardization of Bladder Cancer Care 
  Barcelona, Spain - 1/1/2013
• Inflammation and Bladder Cancer; A Tale of Translation 
  University of Connecticut - 1/1/2011
• Oral inhibitors of Macrophage Migratory Inhibitory Factor (MIF) lead to reduced tumor burden in a murine model of invasive bladder cancer 
  San Francisco, CA - 1/1/2010
• Prostate Cancer Screening, Diagnosis and Treatment in the Elderly 
  Orlando, FL - 1/1/2010
• Role of Frailty and Physical Performance in Bladder Cancer Outcomes in the Elderly 
  University of Connecticut - 1/1/2010
• Expression of the genomic organizer special AT-rich sequence binding protein-1 (SATB1) in bladder cancer cell lines 
  Washington, DC - 1/1/2009
• Age increases the expression of inflammatory genes in a mouse model of bladder cancer 
  Washington, DC - 1/1/2009
• The clinical utility of urine cytology and fluorescence in situ hybridization (FISH) for detecting transitional cell carcinoma (TCC) in a Veteran’s Administration (VA)... 
  Chicago, IL - 1/1/2009
• The current state of funding for Urologic research 
  PR - 1/1/2008
• Management of high grade bladder cancer 
  PR - 1/1/2008
• When is ‘Prostatism’ not due to the prostate 
  Washington, DC - 1/1/2008
• The Role of the Inflammatory Microenvironment in Bladder Cancer & Aging 
  Yale University - 1/1/2008
• Inflammation, inflammatory cytokines and invasive bladder cancer 
  University of Connecticut - 1/1/2008
• Join now to see all

Other

• GRS Teaching Slides 
  Taylor JA, American Geriatrics Society
  http://www.geriatricscareonline.org
  NY - 1/1/2013